Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of small molecule inhibitor JQ1
Abstract The bromodomain protein Brd4 is an epigenetic reader and plays a critical role in the development and maintenance of leukemia. Brd4 binds to acetylated histone tails and activates transcription by recruiting the positive elongation factor P-TEFb. Small molecule inhibitor JQ1 competitively b...
Guardado en:
Autores principales: | Tim-Michael Decker, Michael Kluge, Stefan Krebs, Nilay Shah, Helmut Blum, Caroline C. Friedel, Dirk Eick |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ba77fcb301da4351a857a418f3d765e0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
por: Thomas C. Roberts, et al.
Publicado: (2017) -
Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction
por: Mingzhu Yin, et al.
Publicado: (2020) -
BRD4-mediated repression of p53 is a target for combination therapy in AML
por: Anne-Louise Latif, et al.
Publicado: (2021) -
Phosphorylation-dependent BRD4 dimerization and implications for therapeutic inhibition of BET family proteins
por: Francesca Malvezzi, et al.
Publicado: (2021) -
Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival
por: Marco Segatto, et al.
Publicado: (2017)